LBA Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$14K Hold
550
0.01% 297
2016
Q4
$12K Sell
550
-850
-61% -$18.5K 0.01% 307
2016
Q3
$33K Buy
1,400
+500
+56% +$11.9K 0.02% 231
2016
Q2
$21K Hold
900
0.01% 250
2016
Q1
$17K Sell
900
-750
-45% -$13.2K 0.01% 258
2015
Q4
$30K Buy
1,650
+1,500
+1,000% +$26.9K 0.02% 240
2015
Q3
$2K Hold
150
﹤0.01% 315
2015
Q2
$3K Hold
150
﹤0.01% 288
2015
Q1
$3K Buy
+150
New +$2.37K ﹤0.01% 281

Other funds holding BSX

LBA Wealth Management's BSX Position: Q1 2017 in Review

LBA Wealth Management held its Boston Scientific (BSX) position steady in Q1 2017 at 550 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #297.

LBA Wealth Management first reported a position in BSX in Q1 2015 and has held it in 9 quarters since. The position peaked at $33K in Q3 2016. 552 funds tracked by Wall St. Rank hold BSX as of Q1 2017.

  • LBA Wealth Management held 550 shares of Boston Scientific worth $14K as of Q1 2017.
  • LBA Wealth Management left its Boston Scientific share count unchanged in Q1 2017.
  • Boston Scientific made up 0.01% of LBA Wealth Management's portfolio in Q1 2017, its #297 holding.
  • LBA Wealth Management first reported a position in Boston Scientific in Q1 2015 and has held it in 9 quarters since.
  • LBA Wealth Management's Boston Scientific position peaked at $33K in Q3 2016.
  • 552 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2017.

Based on LBA Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.